S-EPMC10282687 - Multikinase inhibitor-based immunotherapy doublet for advanced hepatocellular carcinoma: its efficacy still needs to be determined. - OmicsDI

Unknown

Dataset Information

Multikinase inhibitor-based immunotherapy doublet for advanced hepatocellular carcinoma: its efficacy still needs to be determined.

ABSTRACT:

SUBMITTER: Li H

PROVIDER: S-EPMC10282687 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature